Mirum Pharmaceuticals, Inc. MIRM Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s operating lease liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liabilities of -$583K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease liabilities decreased by 42.9% year-over-year, from -$408K to -$583K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 30.7% compound annual growth rate (CAGR), from -$649K to -$1.9M.